News
Hosted on MSN1mon
The GLP-1 drug shortage is over. What’s next for the compounders?The forum is one of many that exist online to discuss compounded GLP-1RAs—a pharma subsector that has grown significantly as the interest in GLP-1RAs has skyrocketed in the last few years.
A new study has found GLP-1s may reduce the risk of developing ... A microsimulation model published in JAMA Health Forum projected that Medicare expenditures would increase by $47.7 billion ...
In 2024, 4% of U.S. adults were prescribed a GLP-1 therapy — a 363.7% increase from 0.9% in 2019, according to a Fair Health analysis of more than 51 billion commercial claim records.
The research will focus on the use of GLP-1 receptor agonist medications and their possible cognitive benefits in aging ...
You may soon be able to eat your Ozempic … sort of. GLP-1 supplements are booming, promising to deliver similar benefits to Ozempic and Wegovy without the pricey injections. The latest contender ...
Every item on this page was chosen by an ELLE editor. We may earn commission on some of the items you choose to buy. Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs ...
But shedding pounds and keeping them off requires more than medicine. One of the latest GLP-1 advancements is Eli Lilly's new oral obesity drug, Orforglipron, which during testing helped reduce weight ...
The author supplements GLP-1 medication with vitamins and gummies to combat side effects and support overall health. Supplements mentioned include fiber, digestive enzymes, vitamins D and B12 ...
The use of glucagon-like peptide 1 (GLP-1) medications amongst women – particularly those of childbearing age – has risen dramatically in recent years. From 2020 to 2023, the rate of young ...
Women often experience atypical cardiovascular symptoms and are at a higher risk for heart failure. Clinical studies have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results